DK3572405T3 - Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer - Google Patents

Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer Download PDF

Info

Publication number
DK3572405T3
DK3572405T3 DK19185319.1T DK19185319T DK3572405T3 DK 3572405 T3 DK3572405 T3 DK 3572405T3 DK 19185319 T DK19185319 T DK 19185319T DK 3572405 T3 DK3572405 T3 DK 3572405T3
Authority
DK
Denmark
Prior art keywords
benzoimidazole
amides
channel activators
activators
channel
Prior art date
Application number
DK19185319.1T
Other languages
English (en)
Inventor
Lynn Resnick
George T Topalov
Steven A Boyd
Justin K Belardi
Charles A Flentge
Scott S Harried
David A Mareska
Kai Zhang
James S Hale
Original Assignee
Biohaven Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohaven Therapeutics Ltd filed Critical Biohaven Therapeutics Ltd
Application granted granted Critical
Publication of DK3572405T3 publication Critical patent/DK3572405T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK19185319.1T 2014-09-12 2015-09-14 Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer DK3572405T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462050023P 2014-09-12 2014-09-12
EP15840730.4A EP3191457B1 (en) 2014-09-12 2015-09-14 BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS

Publications (1)

Publication Number Publication Date
DK3572405T3 true DK3572405T3 (da) 2023-10-16

Family

ID=55454102

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19185319.1T DK3572405T3 (da) 2014-09-12 2015-09-14 Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer
DK15840730.4T DK3191457T3 (da) 2014-09-12 2015-09-14 BENZOIMIDAZOL-1,2-YL AMIDER SOM Kv7-KANALAKTIVATORER

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK15840730.4T DK3191457T3 (da) 2014-09-12 2015-09-14 BENZOIMIDAZOL-1,2-YL AMIDER SOM Kv7-KANALAKTIVATORER

Country Status (13)

Country Link
US (5) US9481653B2 (da)
EP (3) EP3572405B9 (da)
DK (2) DK3572405T3 (da)
ES (2) ES2960991T3 (da)
FI (1) FI3572405T3 (da)
HR (1) HRP20231071T1 (da)
HU (1) HUE064331T2 (da)
LT (1) LT3572405T (da)
PL (1) PL3572405T3 (da)
PT (1) PT3572405T (da)
RS (1) RS64708B1 (da)
SI (1) SI3572405T1 (da)
WO (2) WO2016040952A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014145852A2 (en) * 2013-03-15 2014-09-18 Knopp Biosciences Llc Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
EP3572405B9 (en) 2014-09-12 2023-12-06 Biohaven Therapeutics Ltd. Benzoimidazol-1,2-yl amides as kv7 channel activators
EP4241843A3 (en) * 2018-02-20 2023-09-27 H. Lundbeck A/S Alcohol derivatives as kv7 potassium channel openers
US10590067B2 (en) 2018-02-20 2020-03-17 H. Lundbeck A/S Alcohol derivatives of carboxamides as Kv7 potassium channel openers
US10851067B2 (en) * 2018-03-19 2020-12-01 Knopp Biosciences Llc Kv7 channel activators compositions and methods of use
AR119521A1 (es) 2019-08-02 2021-12-22 H Lundbeck As DERIVADOS DE ALCOHOL COMO ABRIDORES DEL CANAL DE POTASIO Kv7
US20220227716A1 (en) * 2019-08-28 2022-07-21 Ferro Therapeutics, Inc. Benzimidazole and hydrogenated carbazole derivatives as gpx4 inhibitors
JP2022548631A (ja) * 2019-09-17 2022-11-21 ノップ バイオサイエンシーズ エルエルシー Kv7チャネル活性化剤の使用方法
WO2023133256A1 (en) * 2022-01-07 2023-07-13 Biohaven Therapeutics Ltd. Pyrazolo[1,5-a]pyridin-2,3-yl amides as kv7 channel activators
WO2024054811A1 (en) * 2022-09-06 2024-03-14 Biohaven Therapeutics Ltd. Combination therapies including metal channel activators

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1022554A (en) 1973-03-07 1977-12-13 Haukur Kristinsson 1-carbamoyl-2-alkoxycarbonylaminoimidazo (4,5-b) pyridines
US4002623A (en) 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
ES473201A1 (es) 1977-09-26 1979-03-16 Degussa Procedimiento para la preparacion de 7-azabencimidazoles
US4391811A (en) 1981-10-02 1983-07-05 Sterling Drug Inc. 2-Amino-6-(pyridinyl)-3H-imidazo[4,5-b]pyridines and their cardiotonic use
JPH0772181B2 (ja) * 1989-06-26 1995-08-02 株式会社大塚製薬工場 ベンズイミダゾール誘導体
JPH0772181A (ja) 1993-09-03 1995-03-17 Advantest Corp 電位波形測定方法および装置
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
KR100547929B1 (ko) 1997-09-26 2006-02-02 젠타리스 게엠베하 세린/트레오닌 단백질 키나제 기능을 조절하기 위한 아자벤즈이미다졸계 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US20030109549A1 (en) * 1999-08-05 2003-06-12 Fumitaka Ito 2-Substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists
JP2001199968A (ja) 2000-01-18 2001-07-24 Teijin Ltd アミノベンズイミダゾール誘導体
US6384049B1 (en) 2000-05-25 2002-05-07 The Procter & Gamble Company Cancer treatment
US6855714B2 (en) * 2001-07-06 2005-02-15 Schering Aktiengesellschaft 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
FR2846656B1 (fr) 2002-11-05 2004-12-24 Servier Lab Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SE0301701D0 (sv) * 2003-06-10 2003-06-10 Astrazeneca Ab Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2005021547A2 (en) 2003-08-28 2005-03-10 Pharmaxis Pty Ltd. Heterocyclic cannabinoid cb2 receptor antagonists
EP1838690A2 (en) 2004-12-21 2007-10-03 Devgen N.V. Compounds with kv4 ion channel activity
US20080146536A1 (en) 2005-08-16 2008-06-19 Pharmacopeia, Inc. 2-Aminoimidazopyridines for treating neurodegenerative diseases
ES2274712B1 (es) 2005-10-06 2008-03-01 Laboratorios Almirall S.A. Nuevos derivados imidazopiridina.
EP2186804B1 (en) 2007-08-10 2015-06-17 Nippon Soda Co., Ltd. Nitrogen-containing heterocyclic compound and pest control agent
AU2008289101A1 (en) 2007-08-17 2009-02-26 Icagen, Inc. Heterocycles as potassium channel modulators
KR101576695B1 (ko) * 2007-11-22 2015-12-10 젠야쿠코교가부시키가이샤 복소환식 화합물의 비정질체, 이를 포함하는 고체 분산체, 약제 및 그 제조법
GB0723794D0 (en) 2007-12-05 2008-01-16 Lectus Therapeutics Ltd Potassium ion channel modulators and uses thereof
CA2710194C (en) * 2007-12-19 2014-04-22 Amgen Inc. Inhibitors of p13 kinase
WO2010051819A1 (en) * 2008-11-10 2010-05-14 Neurosearch A/S Novel 2,3-diamino-quinazolinone derivatives and their medical use
JP5770102B2 (ja) * 2008-12-19 2015-08-26 ジェネンテック, インコーポレイテッド 複素環化合物と使用方法
WO2010094645A1 (en) 2009-02-17 2010-08-26 Neurosearch A/S Substituted pyridine derivatives and their medical use
KR101675614B1 (ko) 2009-10-29 2016-11-11 벡투라 리미티드 Jak3 키나아제 저해제로서의 n―함유 헤테로아릴 유도체
WO2012003576A1 (en) 2010-07-06 2012-01-12 Université de Montréal Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators
SG186409A1 (en) * 2010-07-08 2013-02-28 Pfizer Piperidinyl pyrimidine amides as kv7 potassium channel openers
JP5795635B2 (ja) * 2010-08-05 2015-10-14 アムジェン インコーポレイテッド 未分化リンパ腫キナーゼを阻害するベンゾイミダゾール化合物およびアザベンゾイミダゾール化合物
WO2014145852A2 (en) 2013-03-15 2014-09-18 Knopp Biosciences Llc Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
EP3572405B9 (en) * 2014-09-12 2023-12-06 Biohaven Therapeutics Ltd. Benzoimidazol-1,2-yl amides as kv7 channel activators
US10851067B2 (en) * 2018-03-19 2020-12-01 Knopp Biosciences Llc Kv7 channel activators compositions and methods of use

Also Published As

Publication number Publication date
EP3572405A1 (en) 2019-11-27
PL3572405T3 (pl) 2023-11-13
WO2016040952A3 (en) 2016-05-06
WO2018081825A1 (en) 2018-05-03
RS64708B1 (sr) 2023-11-30
HRP20231071T1 (hr) 2024-03-01
EP3191457B1 (en) 2019-07-10
US10385025B2 (en) 2019-08-20
ES2749103T3 (es) 2020-03-19
EP3572405B8 (en) 2023-09-06
HUE064331T2 (hu) 2024-03-28
WO2016040952A2 (en) 2016-03-17
PT3572405T (pt) 2023-10-26
US20170114022A1 (en) 2017-04-27
LT3572405T (lt) 2023-10-25
ES2960991T3 (es) 2024-03-07
FI3572405T3 (fi) 2023-09-22
EP4289822A3 (en) 2024-01-24
US20160075663A1 (en) 2016-03-17
US20200002292A1 (en) 2020-01-02
DK3191457T3 (da) 2019-10-07
EP3572405B1 (en) 2023-07-26
US9914708B2 (en) 2018-03-13
SI3572405T1 (sl) 2023-12-29
EP3572405B9 (en) 2023-12-06
US10906877B2 (en) 2021-02-02
EP3191457A2 (en) 2017-07-19
US20210188782A1 (en) 2021-06-24
EP3191457A4 (en) 2018-02-07
US20180148419A1 (en) 2018-05-31
US11834418B2 (en) 2023-12-05
US9481653B2 (en) 2016-11-01
EP4289822A2 (en) 2023-12-13

Similar Documents

Publication Publication Date Title
DK3572405T3 (da) Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer
BR112017004332A2 (pt) perfis.
BR112017012364A2 (pt) pré-tratamento rápido.
DK3352625T3 (da) Reorganiserbar liggestol til flere formål, flere anvendelser
CL2014003447S1 (es) Refrigerador.
ZA201703498B (en) Kcnq2-5 channel activator
BR112017012358A2 (pt) artigo absorvente.
DK3158847T3 (da) Bæreanordning
DK3204357T3 (da) Fluorescerende, syntetiske retinoider
DK3250774T3 (da) Port, især hurtigt løbende port
BR112016030583A2 (pt) corante microambiente
DK3237407T3 (da) 3,5-diaminopyrazolkinasehæmmere
ES1141490Y (es) Mochila
ES1147033Y (es) Mochila adaptable
DK3448845T3 (da) Substituerede 2-alkylimidazolyl-carboxamider som skadedyrsbekæmpelsesmiddel
UA31600S (uk) Рюкзак
UA31599S (uk) Рюкзак
ES1148485Y (es) Mochila mejorada
UA30065S (uk) Рюкзак
TH1601002675B (th) ชิ้นส่วนรองลื่นแบบเลื่อน
TH1601002676B (th) ชิ้นส่วนรองลื่นเเบบเลื่อน
TH1501007026B (th) เครื่องมือสำหรับความงาม
TH1601000369B (th) ผลิตภัณฑ์ดูดซึม
TH1601000370B (th) ผลิตภัณฑ์ดูดซึม
TH1601002634B (th) เครื่องติดฉลาก